{"id":"NCT00499109","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","briefTitle":"Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC","officialTitle":"Randomized Phase III Multicenter Trial of RRM1 & ERCC1 Directed Customized Chemotherapy Versus Standard of Care for 1st Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-05","primaryCompletion":"2013-04","completion":"2013-11","firstPosted":"2007-07-11","resultsPosted":"2014-03-26","lastUpdate":"2014-07-09"},"enrollment":275,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Docetaxel","otherNames":["Taxotere"]},{"type":"DRUG","name":"Vinorelbine","otherNames":["anti-cancer chemotherapy drug"]},{"type":"DRUG","name":"Carboplatin","otherNames":["Paraplatin"]},{"type":"DRUG","name":"Gemcitabine","otherNames":["Gemzar"]}],"arms":[{"label":"E. Dual Agent Chemotherapy","type":"EXPERIMENTAL"},{"label":"C. Standard of Care Control Arm","type":"ACTIVE_COMPARATOR"}],"summary":"This is a clinical research study to evaluate if chemotherapy in the experimental arm (E) results in a better outcome compared to patients in the standard of care arm (C).\n\n2:1 randomization to experimental arm (E) or standard arm (C). In arm E, treatment of dual-agent chemotherapy will be selected based on RRM1 and ERCC1 expression at the protein level. In arm C, treatment of dual-agent chemotherapy will be gemcitabine/carboplatin, i.e., standard of care.","primaryOutcome":{"measure":"Progression Free Survival (PFS)","timeFrame":"6 months","effectByArm":[{"arm":"E. Dual Agent Chemotherapy","deltaMin":52,"sd":null},{"arm":"C. Standard of Care Control Arm","deltaMin":56.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":15},"locations":{"siteCount":9,"countries":["United States","Germany","Puerto Rico"]},"refs":{"pmids":["23690416"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":64},"commonTop":["Fatigue (asthenia, lethargy, malaise)","Nausea","Vomiting","Hair loss/alopecia (scalp or body)","Constipation"]}}